Investigator
Julie Kay Andersen
BUCK INSTITUTE FOR RESEARCH ON AGING · funded by NIA
- Companies
- 2
- Grants
- 2
- Non-dilutive funding
- $1.3M
- First award
- Sep 1, 2022
Resolved onto their grants.
Federal awards on file.
Summed across those awards.
Latest Jun 1, 2024.
Companies from this work
Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.
- BUCK INSTITUTE FOR RESEARCH ON AGINGMomentum in another area
NeuroGrant-only
- BUCK INSTITUTE FOR RESEARCH ON AGINGMomentum in another area
NeuroGrant-only
Grant record
Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.
- R25
Support and Preparation for an Alzheimer's Research Career
$432kJun 1, 2024NIABUCK INSTITUTE FOR RESEARCH ON AGINGNIH RePORTER · 11092211 (opens the source filing in a new tab)
- R01
A smart cell drug (SmaCD) delivery platform for mobile, targetable, and self-regulated combination therapy: a model project to rescue antibodies from Alzheimer's disease (AD) clinical trial failures
$914kSep 1, 2022NIABUCK INSTITUTE FOR RESEARCH ON AGINGNIH RePORTER · 11126840 (opens the source filing in a new tab)
This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources